The Russian Ministry of Health has prepared a draft resolution requiring educational institutions that offer programs in medical and pharmaceutical specialties to obtain a mandatory conclusion from Roszdravnadzor (the Federal Service for Surveillance in Healthcare). The document establishes the procedure for issuing such conclusions, evaluation criteria, grounds for refusal, and regulates the electronic submission of applications through the State Services portal. Decisions on issuing conclusions must be made within 25 working days. The public discussion of the draft will continue until October 23, 2025, and the resolution is scheduled to take effect on March 1, 2026.

According to Valery Afanasyev, Director of the Regulatory Risk Assessment Practice at Baikal Communications Group, the initiative creates a legal mechanism for controlling the quality of specialist training and will improve the transparency of educational institution licensing. The expert notes that the new requirement will serve as an additional safeguard ensuring that faculty qualifications, educational infrastructure, and practical training facilities comply with unified federal standards. This measure aims to strengthen trust in the medical and pharmaceutical education system and enhance the professional training level of graduates.

The full version of the article is available at the link.

Back to news